A structural characterization of the isoniazid Mycobacterium tuberculosis drug target, Rv2971, in its unliganded form

The 1.60 Å resolution crystal structure of the aldo-keto reductase Rv2971, an isoniazid drug target in M. tuberculosis, reveals unique characteristics of the isoniazid-NADPH binding pocket.